Abstract
Background
Various surgical approaches exist for Total Hip Arthroplasty (THA), but approach specific complication rates remain unknown. The purpose of this systematic review and meta-analysis was to compare rates of common complications between surgical approaches.
Methods
Four electronic databases (Medline, Embase, AMED, Ovid Healthstar) were searched from inception to June 2019. Three pairs of reviewers were involved in determining eligibility, rating internal and external validity, and data extraction. Pooled estimates were generated using a random-effects model and relative risk (RR) was calculated for dislocation, intraoperative and early postoperative fracture, early infection, deep vein thrombosis (DVT), wound complication, and failure of implant ingrowth between four approaches (posterior, anterior, direct lateral, and anterolateral).
Results
Sixty-nine studies (n = 283,036) were included with nineteen randomized control trials, fourteen prospective cohort, and thirty-six retrospective cohort studies (included studies ranged from 1987 to 2019). When compared to the posterior approach, the risk for dislocation was significantly lower in the anterior (RR 0.66, 95% CI 0.54–0.77, p < 0.01), anterolateral (RR 0.50, 95% CI 0.32–0.77, p = 0.03) and lateral (RR 0.74, 95% CI 0.58–0.96, p = 0.02). When compared to the posterior approach, we found higher risk of loosening in the anterolateral (RR 1.89, 95% CI 1.59–2.25, p < 0.01) and lateral (RR 1.21, 95% CI 1.02–1.44, p = 0.03). Overall, evidence was deemed very low and low-quality following GRADE assessment.
Conclusion
Our findings reveal that the posterior approach was associated with a higher risk of dislocation (compared to the anterior, lateral, and anterolateral) but lower risk of loosening (compared to the lateral and anterolateral approach). However, the large number of cohorts and imprecision due to low sample size for most pooled comparisons was still insufficient to confidently conclude that one approach is superior to another. Each approach has its own strengths and weaknesses, and surgeons can use the approach they are most comfortable with.
Keywords: Total Hip Arthroplasty, Systematic review, Meta-analysis, Complications
Level of evidence
Level 2.
1. Introduction
The question of which surgical approach is superior during Total Hip Arthroplasty (THA) has recently emerged given the various approaches that now exist. Importantly, how these approaches influence intra and post-operative complications have been analyzed in recent literature through multiple comparison studies. While reported complication rates from THA are low, the most commonly cited complications include wound complication, deep vein thrombosis, neural deficit, dislocation, and fracture.1,2
Currently used approaches differ in incision, surgical planes and technique utilized, and reported post-operative complication rates.3 Given this variability, debate continues as to which is the most effective. The most common approaches include posterior4 (or Moore), direct anterior (or Heuter), direct lateral (or Hardinge), and anterolateral (or Watson-Jones). The posterior approach has been associated with a greater risk of postoperative dislocation due to the disruption of the posterior joint capsule,5 while the direct lateral approach has been associated with an increased risk of postoperative abductor weakness, superior gluteal nerve injury, and limping6 due to abductor muscle disruption. The anterolateral approach has been hypothesized to cause superior gluteal nerve injury due to prolonged anterior retraction.7 Finally, the direct anterior approach has been associated with greater wound complications.8,9 Less invasive and muscle sparing techniques to facilitate enhanced recovery pathways have increasingly been emphasized, but the risks and complications are not well known.10
To further understand the risks associated with each approach, we conducted a systematic review and meta-analysis of the literature to compare the incidence of commonly reported complications between different surgical approaches (anterior versus posterior, lateral versus anterior, lateral versus anterolateral, lateral versus posterior, and posterior versus anterolateral).
2. Methods
This systematic review was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)11 and Cochrane guidelines.12
2.1. Literature Search
We systematically searched the electronic databases MEDLINE (1946 to June 2019), AMED (1985 to June 2019), OVID Healthstar (1966 to June 2019), and EMBASE (1946 to June 2019) to identify eligible studies comparing two or more surgical approaches for THA. All studies included were published between 1987 and 2019. Our search strategy is available in Appendix A.
2.2. Study Selection
Three sets of two reviewers independently assessed titles and abstracts from the initial search strategy. Eligible studies included those that (1) evaluated the outcomes of patients who had undergone primary THA, (2) compared two or more surgical approaches including anterior (Smith-Peterson or modified Hueter), posterior (Moore or Southern), direct lateral (Hardinge), or anterolateral (Watson-Jones), (3) included at least one reported complication. We excluded studies that included patients undergoing bilateral THA or hip resurfacing, hip fracture patients, studies evaluating a two-incision technique versus one additional approach, or studies combining two approaches in one cohort. Eligible studies underwent full text review, and disagreement between reviewers was discussed and a third reviewer was consulted if necessary. Inter-rater agreement was determined by a Kappa (K) co-efficient for both titles and abstracts and full text stages. The interpretation of K was as follows: k = 0.81–1.00 as almost perfect agreement, k = 0.61–0.80 as substantial agreement, k = 0.41–0.60 as moderate agreement, and k = 0.21–0.40 as fair agreement.13
2.3. Quality Assessment
Two individuals independently performed quality assessment using the Cochrane Collaboration's tool for assessing risk of bias (RoB) for randomized control trials (RCTs) and the ROBINS I tool for non-randomized studies.14 We used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach to assess the overall quality of the body of evidence as one of four levels: high, moderate, low, or very low quality. Studies were grouped by type and assessed by outcome.15
2.4. Data Collection
Three sets of two reviewers independently extracted data from eligible studies. Information on study design, sample size, demographic characteristics (age, sex, BMI, diagnosis), study period and follow up duration, length of stay, and intra- and postoperative complications was recorded. For dichotomous outcomes, event rates were extracted. We contacted authors by e-mail for further information when needed for clarity.
2.5. Timing of Incidence and Definitions
Surgical approaches were compared on the following complications (1) dislocation, (2) intraoperative femoral fracture, (3) intraoperative acetabular fracture, (4) intraoperative “other” fracture, which includes studies that used only the words “fracture” or “periprosthetic”, (5) early postoperative femoral fracture, (7) early postoperative acetabular fracture, (7) early postoperative “other” fracture, (8) implant loosening, (9) deep vein thrombosis (DVT), (10) wound complication, and (11) early infection. For the purposes of our study, an early complication was defined as within 90 days of surgery. Despite a study not reporting when complications occurred and authors unavailable when emailed, we elected to report additional later time frames for the complications of dislocation, loosening, DVT, and wound complication by reporting study time frame ranges.
2.6. Statistical Analysis
Using RevMan (Version 5), we generated forest plots using a Mantel-Haenszel random effects model to calculate relative risk (RR) ratios and their 95% confidence intervals (CIs). Heterogeneity was assessed using the I2 statistic and Cochrane's X2 test. Based on the threshold guidelines available by Cochrane and Higgins et al., I2 thresholds were 0%–30% (heterogeneity unlikely to be important), 30%–50% (moderate heterogeneity), 50–90% (substantial heterogeneity) and 90%–100% (significant heterogeneity).12,16 For the test of overall effect, p < 0.05 was considered statistically significant. Relative risk and I2 could not be estimated for studies where the event rate in both groups was zero. Where heterogeneity was greater than 50%, we explored heterogeneity through subgroup analysis using the following a priori hypotheses: (a) differences in study design (hypothesizing that RCTs would yield smaller effect sizes than cohorts) and (b) by RoB (hypothesizing that studies with an overall low RoB may generate a smaller effect size than those with a high RoB).
3. Results
3.1. Study characteristics
The initial search identified 4107 articles. Following titles and abstract review, 289 full text studies were assessed. Following full-text review, 69 studies were included (Fig. 1). The studies were categorized by design (19 RCTs, 14 prospective cohorts, and 36 retrospective cohorts). Interrater agreement at the titles and abstracts and full text review stage was substantial (k = 0.61 and k = 0.75, respectively). A total of 283,036 THA patients using one of the four surgical approaches: posterior (n = 185,920), direct lateral (n = 57,437), anterolateral (n = 23,603) and direct anterior (n = 16,076). Study characteristics are available in Appendix B.
Fig. 1.
Preferred reporting items for systematic reviews and meta-analysis flow diagram.
3.2. Methodological quality assessment
RoB assessments for each study is available in Appendix C. The RCTs (n = 19) revealed most studies had a low or unclear risk of selection bias in both random sequence generation and concealed treatment allocation. Performance bias was deemed low in the majority of studies (16/19) because surgeons were considered experienced in the approach. Detection bias was primarily low due to sufficient blinding of outcome assessors or unclear when no information was available. Assessment of the cohort studies (n = 50) revealed that the majority of studies were low RoB on intervention classification and deviation from intervention. However, confounding was a concern where almost half of the studies were at a moderate RoB due to different implants used within the same study,17 differences in post-operative rehabilitation protocol,18 and differences in follow up period within the same study. Selection bias was also a concern where eight studies were deemed serious risk due to patients being included into a group based on the preference of the surgeon or expertise. Notably, nearly a third of studies were deemed moderate RoB for outcome assessment, where assessors were not blinded, and knowledge of the approach could have influenced the reported complications. The overall quality of evidence using the GRADE approach found that most studies were deemed very low or low, indicating that the true effect might be markedly different from the estimated effect. A common theme was that evidence was rated down for imprecision due to low sample size, and for serious limitations due to high or moderate RoB. In some cases, publication bias was strongly suspected as evident by asymmetrical funnel plots which could be due to selective reporting bias or poor study design. Detailed GRADE evidence profiles are available in Appendix D.
3.3. Anterior versus posterior approach
Twenty-nine studies were included in the analysis between anterior versus posterior approach: 4 were RCTs, 5 were prospective cohorts, and 20 were retrospective cohorts. The results of the meta-analysis on intraoperative femoral fracture, intraoperative “other” fracture, early postoperative femoral fracture, early postoperative “other” fracture, wound complication, loosening, and early infection demonstrated no significant difference between approaches (Table 1). Twenty-five studies reported an overall significantly lower risk of dislocation in the anterior approach (RR 0.66, 95% CI 0.56–0.77, p < 0.001, I2 = 0%) with a study time frame range from 1 month to 8 years (Fig. 2).
Table 1.
Summary of findings on complications in anterior versus posterior approach.
| Complication | Number of Studies | Overall GRADE | Anterior | Posterior | RR (95% CI) | P-value | I2 |
|---|---|---|---|---|---|---|---|
| Dislocation*† | 3 RCTs | ⊕⊕⊖⊖ | 166/22,563 | 1838/163,582 | 0.66 (0.56–0.77) | <0.00001 | 0% |
| 22 cohorts | ⊕⊖⊖⊖ | ||||||
| Intraoperative Femoral Fracture | 3 RCTs | ⊕⊕⊖⊖ | 19/1821 | 15/1657 | 1.31 (0.66–2.61) | 0.45 | 0% |
| 6 Cohorts | ⊕⊖⊖⊖ | ||||||
| Intraoperative Acetabular Fracture | 2 Cohorts | ⊕⊖⊖⊖ | 1/46 | 0/46 | 0.69 (0.04–11.12) | 0.79 | 39% |
| Intraoperative “Other” Fracture | 3 Cohorts | ⊕⊕⊖⊖ | 8/404 | 3/317 | 1.16(0.13–10.57) | 0.90 | 47% |
| Postoperative Femoral Fracture* | 1 RCT | ⊕⊕⊖⊖ | 2/101 | 0/104 | 3.12 (0.33–29.50) | 0.32 | 0% |
| 1 Cohort | ⊕⊖⊖⊖ | ||||||
| Postoperative “Other” Fracture* | 3 Cohorts | ⊕⊖⊖⊖ | 6/355 | 1/273 | 1.86 (0.07–49.48) | 0.52 | 20% |
| Wound Complication† | 4 RCTs | ⊕⊕⊖⊖ | 33/2747 | 24/2521 | 1.15 (0.39–3.42) | 0.80 | 47% |
| 3 Cohorts | ⊕⊖⊖⊖ | ||||||
| Infection* | 3 Cohorts | ⊕⊖⊖⊖ | 4/177 | 4/113 | 0.70 (0.15–3.27) | 0.65 | 0% |
| DVT† | 1 RCT | ⊕⊕⊖⊖ | 49/3352 | 480/23,882 | 0.76 (0.57–1.02) | 0.06 | 0% |
| 3 Cohorts | ⊕⊖⊖⊖ | ||||||
| Loosening† | 5 Cohorts | ⊕⊖⊖⊖ | 118/16,758 | 677/106,971 | 1.15 (0.94–1.40) | 0.17 | 0% |
*early (within 90 days), †unknown time, “Not estimable”: not enough studies to conduct meta-analysis.
⊕⊖⊖⊖ (Very Low), ⊕⊕⊖⊖ (Low), ⊕⊕⊕⊖ (Moderate), ⊕⊕⊕⊕ (High).
Fig. 2.
Forest plot for dislocation rates between the anterior versus posterior approach.
3.4. Lateral versus anterior approach
Nineteen studies were included in the analysis between lateral versus anterior approach: 6 were RCTs, 4 were prospective cohorts and 9 were retrospective cohorts. The results of the meta-analyses on dislocation, intraoperative femoral fracture, intraoperative “other” fracture, early postoperative femoral fracture, early postoperative “other” fracture, DVT, and early infection demonstrated no significant difference between approaches (Table 2).
Table 2.
Summary of meta-analyses on complications in lateral versus anterior approach.
| Complication | Number of Studies | Overall GRADE | Lateral | Anterior | RR (95% CI) | P-value | I2 |
|---|---|---|---|---|---|---|---|
| Dislocation*† | 12 Cohorts | ⊕⊖⊖⊖ | 191/37,965 | 87/17,770 | 1.15 (0.88–1.49) | 0.31 | 0% |
| 3 RCTs | ⊕⊕⊕⊖ | ||||||
| Intraoperative Femoral Fracture | 2 RCTs | ⊕⊕⊕⊖ | 7/582 | 12/664 | 0.59 (0.22–1.61) | 0.30 | 0% |
| 3 Cohorts | ⊕⊖⊖⊖ | ||||||
| Intraoperative Acetabular Fracture | 1 Cohort | ⊕⊖⊖⊖ | 0/258 | 1/372 | Not estimable | ||
| Intraoperative “Other” Fracture | 1 RCT | ⊕⊕⊖⊖ | 10/766 | 8/737 | 1.10 (0.44–2.74) | 0.84 | 0% |
| 5 Cohorts | ⊕⊖⊖⊖ | ||||||
| Postoperative Femoral Fracture* | 2 Cohorts | ⊕⊖⊖⊖ | 1/392 | 5/278 | 0.25 (0.04–1.66) | 0.15 | 0% |
| Postoperative Acetabular Fracture* | 1 Cohort | ⊕⊖⊖⊖ | 0/372 | 4/258 | Not estimable | ||
| Postoperative “Other” Fracture* | 1 Cohort | ⊕⊖⊖⊖ | 0/40 | 1/40 | Not estimable | ||
| Infection* | 3 RCTs | ⊕⊕⊕⊖ | 4/610 | 13/907 | 0.57 (0.23–1.52) | 0.26 | 0% |
| 2 Cohorts | ⊕⊖⊖⊖ | ||||||
| DVT† | 2 RCT | ⊕⊕⊕⊖ | 0/771 | 6/615 | 0.26 (0.06–1.15) | 0.08 | 0% |
| 4 Cohorts | ⊕⊖⊖⊖ | ||||||
| Loosening† | 4 Cohorts | ⊕⊕⊖⊖ | 314/36,687 | 118/15,414 | 0.80 (0.40–1.58) | 0.52 | 17% |
| 2 RCT | ⊕⊕⊖⊖ | ||||||
*early (within 90 days), †unknown time, “Not estimable”: not enough studies to conduct meta-analysis.
3.5. Lateral versus anterolateral approach
Six studies were included in the analysis between lateral versus anterolateral approach: 5 were RCTs, and one was a retrospective cohort. The results of the meta-analysis on dislocation, intraoperative femoral fracture, intraoperative “other” fracture, wound complication, early infection, DVT and loosening demonstrated no significant difference between approaches (Table 3).
Table 3.
Summary of meta-analyses complications in lateral versus anterolateral approach.
| Complication | Number of Studies | Overall GRADE | Lateral | Anterolateral | RR (95% CI) | P-value | I2 | |
|---|---|---|---|---|---|---|---|---|
| Dislocation*† | 3 RCTs | ⊕⊕⊖⊖ | 173/37,015 | 68/17,475 | 1.07 (0.80–1.43) | 0.64 | 0% | |
| 4 Cohorts | ⊕⊖⊖⊖ | |||||||
| Intraoperative Femoral Fracture | 2 RCTs | ⊕⊕⊕⊖ | 4/530 | 3/163 | 0.66 (0.16–2.76) | 0.57 | 0% | |
| 2 Cohorts | ⊕⊕⊖⊖ | |||||||
| Intraoperative “Other” Fracture | 1 Cohort | ⊕⊖⊖⊖ | 126/35,830 | 43/12,744 | Not estimable | |||
| Wound Complication† | 2 RCTs | ⊕⊕⊖⊖ | 2/47 | 2/43 | 0.88 (0.13–5.72) | 0.89 | 0% | |
| Infection* | 2 RCTs | ⊕⊕⊖⊖ | 1/93 | 1/92 | 0.99 (0.10–9.35) | 0.99 | 0% | |
| DVT† | 1 RCT | ⊕⊕⊖⊖ | 0/42 | 1/41 | Not estimable | |||
| Loosening† | 2 Cohorts | ⊕⊖⊖⊖ | 313/36,223 | 159/12,774 | 0.36 (0.05–2.65) | 0.32 | 60% | |
*Early (within 90 days), †Unknown Time, “Not estimable”: not enough studies to conduct meta-analysis.
3.6. Lateral versus posterior approach
Twelve studies were included in the analysis between lateral versus posterior approach: 2 were RCTs, 4 were prospective cohorts, and 6 were retrospective cohorts. The results of the meta-analysis on intraoperative femoral fracture, early infection, and DVT demonstrated no significant difference between approaches (Table 4). When pooled, twelve studies found a significantly lower risk in dislocation in the lateral approach (RR 0.74, 95% CI 0.58–0.96, p = 0.02, I2 = 24%) with a study time frame of 90 days to 17 years (Fig. 3). On the other hand, four cohort studies found a lower risk of implant loosening in the posterior approach (RR 1.21, 95% CI 1.02–1.44, p = 0.03, I2 = 48%) with a study time frame range of 5 months–17 years (Fig. 4). Importantly, the lower boundary of the 95% CIs suggests that the benefit could be as low as 2% in favour of the posterior approach.
Table 4.
Summary of meta-analyses complications in lateral versus posterior approach.
| Complication | Number of Studies | Overall GRADE | Lateral | Posterior | RR (95% CI) | P-value | I2 |
|---|---|---|---|---|---|---|---|
| Dislocation*† | 2 RCTs | ⊕⊕⊖⊖ | 314/60,705 | 1145/151,943 | 0.74 (0.58–0.96) | 0.02 | 24% |
| 10 Cohorts | ⊕⊖⊖⊖ | ||||||
| Intraoperative Femoral Fracture | 2 RCT | ⊕⊕⊕⊖ | 5/257 | 2/231 | 1.57(0.36, 6.95) | 0.55 | 0% |
| 2 Cohorts | ⊕⊖⊖⊖ | ||||||
| Postoperative “Other” Fracture* | 1 Cohort | ⊕⊕⊖⊖ | 0/40 | 1/40 | Not estimable | ||
| Infection* | 1 RCT | ⊕⊕⊕⊖ | 2/30 | 0/30 | Not estimable | ||
| DVT† | 1 RCT | ⊕⊕⊕⊖ | 2/109 | 2/127 | 1.48 (0.18–12.24) | 0.71 | 28% |
| 2 Cohorts | ⊕⊖⊖⊖ | ||||||
| Loosening† | 4 Cohorts | ⊕⊖⊖⊖ | 896/52,674 | 877/107,549 | 1.21 (1.02–1.44) | 0.03 | 48% |
*Early (within 90 days), †Unknown Time, “Not estimable”: not enough studies to conduct meta-analysis.
Fig. 3.
Forest plot for dislocation rates between lateral versus posterior approach.
Fig. 4.
Forest plot for implant loosening rates between lateral versus posterior approach.
3.7. Anterolateral versus posterior approach
Nine studies were included in the analysis between anterolateral versus posterior approach: 2 were RCTs, 3 were prospective cohorts, and 4 were retrospective cohorts. The results of the meta-analysis on intraoperative femoral fracture, early infection, and loosening demonstrated no significant difference between approaches (Table 5). Eleven studies found a lower dislocation risk in favour of the anterolateral approach (RR 0.50, 95% CI 0.32–0.77, p = 0.03) with a study time frame range from 90 days to 10 years (Fig. 5). We detected considerable heterogeneity (I2 = 71%) but subgroup analyses based on a priori hypotheses were unable to resolve heterogeneity. Two studies report an overall lower risk of loosening in favour of the posterior approach (RR 1.89, 95% CI 1.59–2.25, p < 0.001, I2 = 0%) with a study time frame range from 6 months to 6 years (Fig. 6). However, one large cohort study was contributing nearly all of the weighted estimated (99.7%) and the limitations and findings of the pooled analysis were not different from the single study.
Table 5.
Summary of complications in anterolateral versus posterior approach.
| Complication | Studies (N) | Overall GRADE | Anterolateral | Posterior | RR (95% CI) | P-value | I2 |
|---|---|---|---|---|---|---|---|
| Dislocation*† | 10 Cohorts | ⊕⊖⊖⊖ | 175/23,298 | 1228/139,704 | 0.50 (0.32, 0.77) | 0.002 | 71% |
| 1 RCT | ⊕⊕⊕⊖ | ||||||
| Intraoperative Femoral Fracture | 1 RCT | ⊕⊕⊖⊖ | 1/73 | 6/65 | 0.20 (0.04–1.16) | 0.07 | 0% |
| 1 Cohort | ⊕⊖⊖⊖ | ||||||
| Wound Complication† | 1 Cohort | ⊕⊖⊖⊖ | 0/35 | 1/43 | Not estimable | ||
| Infection* | 2 RCTs | ⊕⊕⊕⊖ | 2/45 | 1/63 | 2.13 (0.35–12.83) | 0.42 | 0% |
| 1 Cohort | ⊕⊖⊖⊖ | ||||||
| DVT† | 1 Cohort | ⊕⊖⊖⊖ | 4/37 | 0/37 | Not estimable | ||
| Loosening† | 1 RCT | ⊕⊕⊖⊖ | 160/12,786 | 663/100,874 | 1.89 (1.59–2.25) | 0.0001 | 0% |
| 2 Cohorts | ⊕⊖⊖⊖ | ||||||
*Early (within 90 days), †Unknown Time, “Not estimable”: not enough studies to conduct meta-analysis.
Fig. 5.
Forest plot for dislocation rates between anterolateral versus posterior approach.
Fig. 6.
Forest plot for implant loosening rates between anterolateral versus posterior approach.
4. Discussion
Our findings reveal that few differences exist in common intra- and post-operative complications between frequently performed surgical approaches for THA. When comparing other approaches (anterior, lateral, and anterolateral) to the posterior group, the risk of dislocation was 50%–75% lower. This is consistent with the literature that suggests that the anterior and lateral approaches may have lower rates of dislocations.10,19 In a meta-analysis evaluating the association between soft-tissue repair and dislocation in the posterior approach, an eight times greater risk of dislocation was observed when soft tissue was not repaired, demonstrating the importance of the soft tissues involved.20, 21, 22
The posterior approach was also associated with a lower risk of implant loosening compared to the anterolateral (based on three cohort studies, but one large study primarily contributed to the overall estimate) and lateral approach (based on four cohort studies). However, it is important to note that we did not look at whether studies included cemented or non-cemented implants or differences in prosthesis design which is known to significantly impact loosening and fracture rates, where cemented has been shown to have fewer rates of loosening long term.23,24 Another confounder for the findings of loosening is study time frame. A study with a longer follow up is more likely to find late loosening rates, regardless of surgical approach. Since the range for the study period for our meta-analysis was from six weeks to 17 years, this has implications on our findings since the farther we are from the time of surgery, the more challenging it becomes to attribute to surgical approach alone. In the included studies that were significant for loosening, three admitted the learning curve may influence results,25, 26, 27 while one attempted to control for it by excluding the first 150 cases by each hospital.17 The effect of learning curve has been well demonstrated, with Laffosse et al. reporting a higher rate of intra- and peri-operative complications during the learning curve of the anterolateral approach.28 Our study did not control for the learning curve, but studies were deemed at risk for selection bias due to expertise differences.
The overall quality of evidence was deemed low or very low since the majority of studies were imprecise due to few events. Our meta-analysis was constructed primarily of underpowered RCTs and cohort studies, and large database studies. In particular, Zjilstra et al. used the Dutch Arthroplasty Registry and reported on complications, where the posterior approach group had nearly three times as many patients.17The ability to discern case details is challenging in registry data given the difficulty in obtaining the timing of the complication, as well as the preponderance of posterior approach cases and the recent introduction of new approaches. Further, Zjilstra et al. only reported on dislocations that were treated with a surgical intervention and did not capture non-surgical management of dislocations, which likely means dislocations were under reported. The nature of registry studies also means that selection and detection bias are unclear and complication rates may be influenced by capture rates, and procedure expertise. There is a need for quality registries with uniform reporting techniques and consistency in complication recording in order to better understand differences in approaches.
Limitations include that our conclusions are only as strong as the evidence available, which was primarily level 2 and 3 cohort studies. We did not stratify anterior approach studies for those that evaluated the use of a specialized table for direct anterior cases, which has been associated with increased intra-operative trochanteric fractures,29 and implant type, which has been reported to influence complication rates.25 We also did not capture the sheer breadth of complications that may occur postoperatively, such as limb-length discrepancy, bleeding, limping, and nerve damage. Further, more studies were available for some approaches (posterior, lateral) while fewer were available for less frequently used approaches (anterolateral, anterior) and the effect of these studies may be larger as they are still overcoming the learning curve and random sampling error compared to older procedures. Another important limitation is the variability amongst length of follow up between studies included in our analysis. While some studies gave indications on the timing of complication, others included only final follow up times, or study periods, which ranged from six weeks to 17 years. The changing time periods of these studies as well as the experience of the surgeons may have a major influence on the complications and may explain the extreme variability of the data collected.
The strengths of this study are that it is the first to compare complications rates between multiple approaches, with the inclusion of both RCTs and cohort studies, allowing for a broad scope of the literature. Little heterogeneity allowed us to aggregate all data into forest plots and the inclusion of a range of follow up times in certain complications allowed for studies to be included that otherwise would not have been.
In conclusion, our findings reveal that the posterior approach has higher risk of dislocation (when compared to the anterior, lateral, and anterolateral) but lower risk of loosening (when compared to the lateral and anterolateral approach). However, we believe that the low-quality evidence was insufficient for us to confidently conclude that one approach is superior to another. Given that each approach has its own strengths and weaknesses, surgeons can use the approach they are most comfortable with in context of the patient.
Source of funding
None.
Declaration of competing interest
Dr. Lanting reports grants, personal fees and other from Smith and Nephew, grants, personal fees and other from Stryker, grants, personal fees and other from DePuy, personal fees from IntelliJoint, other from Zimmer, outside the submitted work; Dr. Somerville reports other from Smith and Nephew, Zimmer, Stryker, Depuy, outside the submitted work.
Appendix A.
Search Strategy in OVID Healthstar, AMED, MEDLINE, EMBASE
-
1.
Arthroplasty, replacement, hip/
-
2.
Hip Prosthesis/
-
3.
Or/1-2
-
4.
Arthroplasty/or arthroplasty, replacement/
-
5.
Joint Prosthesis/
-
6.
“Prostheses and Implants"/
-
7.
(arthoplasty or replacement or prosthes#s).tw.
-
8.
Or/4-7
-
9.
Hip/or hip joint/or hip.tw.
-
10.
8 and 9
-
11.
3 or 10
-
12.
Kocher-langenbeck.tw.
-
13.
Posterior.tw.
-
14.
12 or 13
-
15.
3 and 14
-
16.
Hardinge.tw.
-
17.
Lateral.tw.
-
18.
16 or 17
-
19.
3 and 18
-
20.
3 and 18
-
21.
(anterior or direct anterior).tw.
-
22.
3 and 21
-
23.
Watson-jones.tw.
-
24.
3 and 23
-
25.
(smith-petersen or heuter).tw.
-
26.
3 and 25
-
27.
Minimally invasive.tw.
-
28.
3 and 27
-
29.
Two incision.tw.
-
30.
3 and 29
-
31.
(mt or su).fs.
-
32.
11 and 31
-
33.
15 or 19 or 22 or 24 or 26 or 28 or 30
-
34.
32 and 33
Appendix B.
Table 1.
Study demographics for anterior versus posterior approach.
| Study | Study Type | Participants | Male (%) | Female (%) | Mean Age (SD) | Mean BMI (SD) | Study Time Frame |
|---|---|---|---|---|---|---|---|
| Bergin et al., 2011 | P.C. | 4 weeks | |||||
| Anterior | 29 | 34 | 66 | 69 (9) | 26 (5) | ||
| Posterior | 28 | 50 | 50 | 65 (11) | 29 (5) | ||
| Hananouchi et al., 2009 | P.C. | 1 year | |||||
| Anterior | 20 | 10 | 90 | 55 (6) | 22 (3) | ||
| Posterior | 20 | 10 | 90 | 57 (8) | 21 (3) | ||
| Panichkul et al., 2016 | R.C. | 3 years | |||||
| Anterior | 594 | 42 | 58 | 62.3 (11.1) | 28.4 (5.6) | ||
| Posterior | 88 | 22.7 | 77.3 | 72.6 (11) | 28.4(7.2) | ||
| Lateral | 421 | 46.1 | 53.9 | 62.2(12.4) | 29.1(6.3) | ||
| Nakata et al., 2009 | R.C. | 6 months | |||||
| Anterior | 99 | 16 | 84 | 63 (1) | 23 (1) | ||
| Posterior | 96 | 14 | 87 | 65 (11) | 23 (1) | ||
| Spaans et al., 2012 | R.C. | 12 months | |||||
| Anterior | 46 | 52 | 48 | 69 (10) | 25 (3) | ||
| Posterior | 46 | 30 | 70 | 68 (11) | 29 (4) | ||
| Sugano et al., 2009 | R. C. | 24 months | |||||
| Anterior | 39 | 8 | 92 | 57 (12) | 23 (4) | ||
| Posterior | 33 | 12 | 88 | 56 (13) | 23 (4) | ||
| Barrett et al., 2013 | R.C.T. | 12 months | |||||
| Anterior | 43 | 67 | 33 | 61 (9) | 31 (5) | ||
| Posterior | 44 | 43 | 57 | 63 (8) | 29 (4) | ||
| Rodriguez et al., 2014 | P.C. | 12 months | |||||
| Anterior | 67 | 47 | 53 | 60 (10) | 27 (4) | ||
| Posterior | 65 | 43 | 57 | 59 (6) | 28 (4) | ||
| Taunton et al., 2014 | R.C.T. | ||||||
| Anterior | 27 | 44 | 56 | 62 | 28 | ||
| Posterior | 27 | 48 | 52 | 66 | 29 | ||
| Sheth et al., 2015 | R.C. | 10 years | |||||
| Anterior | 1851 | 44 | 56 | 65 (11) | 28 (5) | ||
| Posterior | 31,747 | 43 | 58 | 66 (12) | 29 (6) | ||
| Lateral | 667 | 42 | 58 | 65(11) | 30(6) | ||
| Anterolateral | 4226 | 42 | 58 | 67 (11) | 29 (6) | ||
| Hamilton et al., 2015 | R.C. | Early (90 days) Late (up to 2.5 years) |
|||||
| Anterior | 100 | 36 | 64 | 63 (15) | 29 (7) | ||
| Posterior | 100 | 39 | 61 | 61 (13) | 29 (6) | ||
| Kobayashi et al., 2016 | R.C. | 4 years | |||||
| Anterior | 75 | 11 | 89 | 63 (13) | 24 (4) | ||
| Posterior | 77 | 17 | 83 | 64 (14) | 24 (4) | ||
| Tripuraneni et al., 2016 | R.C. | 3 years (mean) | |||||
| Anterior | 66 | 39 | 61 | 60.2 (N/A) | 27.6 (N/A) | ||
| Posterior | 66 | 39 | 61 | 60.2 (N/A) | 27.8 (N/A) | ||
| Petis et al., 2016 | P.C. | 3 months | |||||
| Anterior | 40 | 37.5 | 62.5 | 66.9(9.5) | 27.9 (4.3) | ||
| Posterior | 38 | 35 | 65 | 66.7(9.2) | 28.2(5.3) | ||
| Lateral | 40 | 35 | 65 | 65.5(10.4) | 29.1(5.6) | ||
| Cheng et al., 2016 | R.C.T. | 3 months | |||||
| Anterior | 35 | 43 | 57 | 59 (4) | 28 (1) | ||
| Posterior | 38 | 47 | 53 | 63 (4) | 28 (2.5) | ||
| Fransen et al., 2016 | R.C. | 12 months | |||||
| Anterior | 45 | 34 | 66 | 64 (9) | 28 (3) | ||
| Posterior | 38 | 37 | 63 | 63 (9) | 25 (3) | ||
| Tsukada et al., 2015 | R.C. | 14 years | |||||
| Anterior | 139 | 10 | 90 | 67 (10) | 23 (3) | ||
| Posterior | 177 | 17 | 83 | 62 10) | 24 (4) | ||
| Zjilstra et al., 2017 | R.C. | 6 years | |||||
| Anterior | 14,446 | 32.2 | 67.8 | N/A | N/A | ||
| Posterior | 100,823 | 32.3 | 67.7 | N/A | N/A | ||
| Anterolateral | 12,744 | 32.9 | 67.1 | N/A | N/A | ||
| Lateral | 35,830 | 31.8 | 68.2 | N/A | N/A | ||
| Poehling-Monaghan et al., 2015 | P.C. | 8 weeks | |||||
| Anterior | 126 | 46 | 54 | 65 (12) | 30 (6) | ||
| Posterior | 96 | 45 | 55 | 64 (13) | 30 (6) | ||
| Purcell et al., 2018 | R. C. | 12 months | |||||
| Anterior | 2424 | 41.5 | 58.5 | 62.6(N/A) | 27.7 (N/A) | ||
| Posterior | 2227 | 47 | 53 | 62.7 (N/A) | 28.2 (N/A) | ||
| Leucht et al., 2014 | R.C. | 3 years (min) | |||||
| Anterior | 100 | 52 | 48 | 59 (14) | 28 (5) | ||
| Posterior | 100 | 57 | 43 | 60 (13) | 29 (7) | ||
| Zawadasky et al., 2013 | R.C. | 6 weeks | |||||
| Anterior | 50 | 44 | 56 | 60.8 (11.8) | 28.6(6.2) | ||
| Posterior | 50 | 28 | 72 | 56. (11.4) | 27.9(6.2) | ||
| Balasubramaniam et al., 2016 | R. C. | 12 months | |||||
| Anterior | 50 | 50 | 50 | 62.5(9.01) | 31.3(5.2) | ||
| Posterior | 42 | 33.3 | 66.7 | 57 (12.84) | 29.9(6.7) | ||
| L'Hommedieu et al., 2016 | R.C. | 3 months | |||||
| Anterior | 3120 | N/A | N/A | N/A | N/A | ||
| Posterior | 23,653 | N/A | N/A | N/A | N/A | ||
| Malek et al., 2016 | R.C. | 18.1 months (mean) | |||||
| Anterior | 265 | 44.2 | 55.8 | 70.8 (N/A) | 28.5(N/A) | ||
| Posterior | 183 | 47 | 53 | 70 (N/A) | 29 (N/A) | ||
| Taunton et al., 2018 | R.C.T. | 12 months | |||||
| Anterior | 52 | 51 | 49 | 65 (10) | 29 (22) | ||
| Posterior | 49 | 51 | 49 | 64 (11) | 30 (4) | ||
| Angerame et al., 2018 | R.C. | ||||||
| Anterior | 2431 | N/A | N/A | N/A | N/A | 7 years | |
| Posterior | 4463 | N/A | N/A | N/A | N/A | ||
| Ponzio et al., 2018 | R.C. | 3.2 years | |||||
| Anterior | 289 | 44.7 | 55.3 | 64.7 (11.2) | 65.1 (9.8) | ||
| Posterior | 4249 | 42.2 | 57.8 | 28.1 (5.7) | 28.4 (5.5) | ||
| Aggrawal et al., 2019 | R.C. | 2 years | |||||
| Anterior | 1329 | 43.0 | 57 | 63.3 | 27.7 | ||
| Posterior | 1657 | 45.5 | 54.5 | 62.5 | 30.1 | ||
| Lateral | 393 | 44.3 | 56.7 | 61 | 29.9 | ||
| Anterolateral | 30 | 53.3 | 47.7 | 63.9 | 27.7 |
R.C.T.: Randomized Control Trial, R.C.: Retrospective Cohort, P.C.: Prospective Cohort.
Table 2.
Study demographics for anterior vs. lateral approach.
| Study | Study Type | Participants | Male (%) | Female (%) | Mean Age (SD) | Mean BMI (SD) | Study Time Frame |
|---|---|---|---|---|---|---|---|
| Berend et al 2009 | R.C. | 5 months | |||||
| Anterior | 258 | N/A | N/A | 63 (N/A) | 28.9 (N/A) | ||
| Lateral | 372 | NA | NA | 63 (N/A) | 30.4(N/A) | ||
| Pogliacomi & DeFilippo et al., 2012 | R.C. | 12 months | |||||
| Anterior | 35 | 54 | 46 | 65 (8) | 27 (2) | ||
| Lateral | 35 | 51 | 49 | 65 (8) | 27 (2) | ||
| Sendtner et al., 2011 | P.C. | 12 months | |||||
| Anterior | 74 | 68 | 32 | 68 (8) | 29 (5) | ||
| Lateral | 60 | 25 | 75 | 68 (9) | 29 (5) | ||
| Dienstknecht et al., 2014 | R.C.T. | 3 months | |||||
| Anterior | 55 | 40 | 60 | 62 (12) | 28 (6) | ||
| Lateral | 88 | 47 | 53 | 61 (12) | 30 (6) | ||
| Pogliacomi & Paraskevopoulos al. 2012 | R.C. | 12 months | |||||
| Anterior | 30 | 50 | 50 | 68 (N/A) | 27 (N/A) | ||
| Lateral | 30 | 47 | 53 | 69 (N/A) | 27 (N/A) | ||
| Reichert et al., 2015 | R.C. | ||||||
| Anterior | 85 | 43 | 57 | 68 (N/A) | 28 (N/A) | 3.3 years (mean) | |
| Lateral | 86 | 56 | 44 | 64 (N/A) | 29 (N/A) | 5.4 years (mean) | |
| Chen et al., 2016 | R.C. | 309.7 days (mean) | |||||
| Anterior | 186 | 52 | 48 | 68 (10) | 30 (5) | ||
| Lateral | 186 | 49 | 51 | 68 (11) | 30 (5) | ||
| Ilchmann et al., 2013 | P.C. | 6 weeks | |||||
| Anterior | 113 | 53 | 47 | 70 (13) | 27 (5) | ||
| Lateral | 142 | ||||||
| De Anta-Diaz et al., 2016 | R.C.T. | 6 months | |||||
| Anterior | 50 | 52 | 48 | 64.8(10.1) | 26.6(3.9) | ||
| Lateral | 49 | 53 | 47 | 63.5 (12.5) | 26.1 (3.1) | ||
| Alecci et al., 2011 | R.C. | NR | |||||
| Anterior | 221 | 45.2 | 54.8 | 70.7 (8.2) | N/A | ||
| Lateral | 198 | 37.9 | 62.1 | 70.15(9.6) | N/A | ||
| Restrepo et al., 2010 | R.C.T. | 2 years | |||||
| Anterior | 50 | 34 | 66 | 62.02 (N/A) | 25.18(N/A) | ||
| Lateral | 50 | 44 | 54 | 59.91 (N/A) | 25.17 (N/A) | ||
| Ilchmann et al., 2016 | P.C. | 2 years | |||||
| Anterior | 700 | 53 | 47 | 71 (median) (10.6) | 26.6 (4.2) | ||
| Lateral | 404 | 49 | 51 | 71 (median) (10.6) | 27.2 (5.2) | ||
| Reichert et al., 2018 | R.C.T. | 12 months | |||||
| Anterior | 77 | 58 | 42 | 63.2 (8.2) | 28.1 (3.7) | ||
| Lateral | 71 | 55 | 45 | 61.9 (7.8) | 28.3 (3.4) | ||
| Brismar et al., 2018 | R.C.T. | ||||||
| Anterior | 50 | 36 | 64 | 66 (58–74) | 27 (24–29) | 5 years | |
| Lateral | 50 | 34 | 66 | 67 (60–76) | 27 (24–30) | ||
| D'Arrigo et al., 2009 | R.C.T. | ||||||
| Anterior | 20 | 60 | 40 | 64 (8) | 23.1 (1.5) | 6 weeks | |
| Lateral | 20 | 70 | 30 | 66.3 (10.4) | 37.6 (3) | ||
| Anterolateral | 20 | 55 | 45 | 66 (7.5) | 23.1 (1.5) | ||
| Wayne & Reinhard et al., 2009 | R.C. | NR | |||||
| Anterior | 100 | 29 | 71 | 68 (35–90) | 26.6 (16–38) | ||
| Lateral | 100 | 34 | 66 | 68 (32–90) | 27.0 (18–42) |
R.C.T.: Randomized Control Trial, R.C.: Retrospective Cohort, P.C.: Prospective Cohort, NR: Not reported.
Table 3.
Study demographics in the posterior vs. lateral approach.
| Study | Study Type | Participants | Male (%) | Female (%) | Mean Age (SD) | Mean BMI (SD) | Study Time Frame |
|---|---|---|---|---|---|---|---|
| Downing et al., 2001 | P.C. | 12 months | |||||
| Lateral | 49 | 41 | 59 | 65(6) | (N/A) | ||
| Posterior | 51 | 49 | 51 | 67 (N/A) | (N/A) | ||
| Schleicher et al., 2011 | P.C. | 6 months | |||||
| Lateral | 64 | 31 | 69 | 69 (9) | 29 (4) | ||
| Posterior | 64 | 25 | 75 | 68 (10) | 27 (4) | ||
| Witzleb et al., 2009 | R.C.T. | 3 months | |||||
| Lateral | 30 | 47 | 53 | 55 (4) | 29 (5) | ||
| Posterior | 30 | 50 | 50 | 58 (5) | 27 (5) | ||
| Vincente et al., 2008 | P.C. | 6 months | |||||
| Lateral | 42 | 62 | 38 | 57 (11) | 27 (4) | ||
| Posterior | 34 | 62 | 38 | 50 (13) | 27 (4) | ||
| Jameson et al., 2014 | R.C. | 12 months | |||||
| Lateral | 816 | 35.9 | 64.1 | 73.2(7.2) | 28.9 (5.1) | ||
| Posterior | 1121 | 31.8 | 68.2 | 72.6(8.1) | 28.6 (4.9) | ||
| Vicente et al., 2014 | R.C.T. | 7.2 years (mean) | |||||
| Lateral | 121 | 57 | 43 | 56 (N/A) | 27 (N/A) | ||
| Posterior | 103 | 53 | 47 | 56 (N/A) | 27 (N/A) | ||
| Arthursson et al., 2007 | R.C. | 17 years | |||||
| Lateral | 16,381 | 28 | 72 | 71 (median) | (N/A) | ||
| Posterior | 6604 | 30.4 | 69.5 | 73 (median) (N/A) | (N/A) | ||
| Amlie et al., 2014 | R.C. | 3 years | |||||
| Lateral | 431 | 36 | 64 | 66 (7.3) | N/A | ||
| Posterior | 421 | 36 | 64 | 66 (7.1) | N/A | ||
| Anterior | 421 | 31 | 69 | 67 (7.1) | N/A | ||
| Chomiak et al., 2015 | R.C. | 9 months | |||||
| Anterolateral | 22 | N/A | N/A | 60.7 (N/A) | N/A | ||
| Posterior | 33 | N/A | N/A | 62 (N/A) | N/A | ||
| Lateral | 15 | N/A | N/A | 66.2(N/A) | N/A |
R.C.T.: Randomized Control Trial, R.C.: Retrospective Cohort, P.C.: Prospective Cohort.
Table 4.
Study demographics for the posterior vs. anterolateral approach.
| Study | Study Type | Participants | Male (%) | Female (%) | Mean Age (SD) | Mean BMI (SD) | Study Time Frame |
|---|---|---|---|---|---|---|---|
| Goosen et al. 2009 | R.C.T. | 12 months | |||||
| Anterolateral | 27 | 53 | 47 | 62 (7) | 26 (3) | ||
| Posterior | 29 | 43 | 57 | 62 (6) | 27 (3) | ||
| Carlson et al., 1987 | P.C. | 12 months | |||||
| Anterolateral | 37 | 92 | 8 | 67 (7) | N/A | ||
| Posterior | 37 | 84 | 16 | 64 (13) | N/A | ||
| Abdel et al., 2016 | R.C. | 27 months (mean) 133 months (last) |
|||||
| Anterolateral | 3384 | N/A | N/A | N/A | N/A | ||
| Posterior | 5765 | N/A | N/A | N/A | N/A | ||
| Laffosse et al., 2007 | P.C. | 6 months | |||||
| Anterolateral | 33 | 60 | 40 | 57 (13) | 26 (4) | ||
| Posterior | 43 | 65 | 35 | 56 (14) | 25 (3) | ||
| Meneghini et al., 2008 | R.C.T. | 6 weeks | |||||
| Anterolateral | 7 | N/A | N/A | 54 (9) | 26 (2) | ||
| Posterior | 8 | N/A | N/A | ||||
| Takao et al., 2016 | P.C. | 12 months | |||||
| Anterolateral | 32 | 9 | 91 | 60 (12) | 23 (N/A) | ||
| Posterior | 57 | 18 | 82 | 63 (11) | 24 (N/A) | ||
| Smith et al., 2012 | R.C. | 3 years | |||||
| Anterolateral | 246 | N/A | N/A | N/A | N/A | ||
| Posterior | 665 | N/A | N/A | N/A | (N/A) | ||
| Ritter et al., 2001 | R.C. | 12 months | |||||
| Anterolateral | 122 | 43 | 57 | 68 | N/A | ||
| Posterior | 184 | 45.3 | 54.7 | 67 | (N/A) | ||
| Edmunds et al., 2011 | R.C. | 1 year (dislocation only) | |||||
| Anterolateral | 2471 | 42.3 | 57.7 | 68.9 | N/A | ||
| Posterior | 362 | 41.2 | 58.8 | 65.7 | (N/A) |
R.C.T.: Randomized Control Trial, R.C.: Retrospective Cohort, P.C.: Prospective Cohort.
Table 5.
Study demographics in the anterolateral vs. lateral approach.
| Study | Study Type | Participants | Male (%) | Female (%) | Mean Age (SD) | Mean BMI (SD) | Study Time Frame |
|---|---|---|---|---|---|---|---|
| Bernasek et al., 2010 | R.C. | 12 months (min) | |||||
| Anterolateral | 47 | N/A | N/A | N/A | 27 (3) | ||
| Direct Lateral | 45 | N/A | N/A | N/A | 31 (4) | ||
| Inaba et al., 2011 | R.C.T. | 12 months | |||||
| Anterolateral | 50 | 24 | 76 | 64 (11) | 23 (4) | ||
| Direct Lateral | 52 | 25 | 75 | 65 (11) | 24 (5) | ||
| Martin et al., 2011 | R.C.T. | 12 months | |||||
| Anterolateral | 42 | 29 | 71 | 67 (10) | 31 (6) | ||
| Direct Lateral | 41 | 34 | 66 | 63 (10) | 29 (6) | ||
| Muller et al., 2012 | R.C.T. | 3 months | |||||
| Anterolateral | 15 | 40 | 60 | 64.3 (7) | 26.9 (3.3) | ||
| Direct Lateral | 15 | 33.3 | 66.7 | 66.2 (8) | 27 (3.1) | ||
| Landgraeber et al., 2013 | R.C.T. | 3.5 years | |||||
| Anterolateral | 28 | 33.3 | 66.7 | 70.26 (4.05) | 27.03(2.82) | ||
| Direct Lateral | 32 | 35 | 65 | 71.03 (5.38) | 26.76 (3.83) | ||
| Pospischill et al., 2010 | R.C.T. | 12 weeks | |||||
| Anterolateral | 20 | 40 | 60 | 61.9 (N/A) | 25.7(N/A) | ||
| Direct lateral | 20 | 40 | 60 | 60.6 (N/A) | 25.7 (N/A/) |
R.C.T: Randomized Control Trial, R.C.: Retrospective Cohort, P.C.: Prospective Cohort.
Appendix C. Risk-of-bias assessment of included articles
Table 1.
Methodological and Quality Assessment of Randomized Control Trials (N = 19)
| Study (Name, Year) | Selection Bias: Random Sequence Generation | Selection Bias: Concealed Treatment Allocation | Performance Bias: Blinded participants and personnel | Detection Bias: Blinded Outcome Assessment | Attrition Bias: Incomplete Outcome Data | Reporting Bias | Other |
|---|---|---|---|---|---|---|---|
| Barrett 2013 | Unclear | Unclear | Low | High | Unclear | Low | None |
| Cheng 2016 | Low | Low | Low | Unclear | Low | Low | None |
| Taunton 2017 | Unclear | Unclear | Low | Unclear | Unclear | Low | None |
| Retrespo 2010 | Low | Low | Low | Low | Low | Low | None |
| Dienstknecht 2014 | Unclear | Unclear | Low | Unclear | Unclear | Low | None |
| De Anta-Diaz 2016 | Low | Low | Unclear | Low | Low | High | None |
| Inaba 2011 | Unclear | High | Unclear | Unclear | Low | Low | None |
| Martin 2011 | Unclear | Unclear | Low | Low | Unclear | Low | None |
| Muller 2012 | Low | Unclear | Low | Low | Low | Low | None |
| Pospichill 2010 | Low | Low | Low | High | Low | Low | None |
| Landgraeber 2013 | Low | Low | Low | Low | Unclear | Low | Study sponsored by Stryker |
| Meneghini 2008 | Low | Unclear | Low | Unclear | Low | Low | None |
| Witzleb 2009 | Low | Low | Low | Low | Unclear | Low | None |
| Vicente 2014 | Low | Low | Unclear | Unclear | Unclear | Low | None |
| Goosen 2011 | Unclear | Unclear | Low | Low | Low | Low | None |
| Taunton 2018 | Unclear | High | High | High | Low | Low | None |
| Reichert 2018 | Low | Unclear | High | High | Low | Low | None |
| Brismar 2018 | Low | Low | High | High | Low | Low | Sponsored by Stryker |
| D'Arrigo 2009 | Unclear | Unclear | High | High | Unclear | Low | None |
Table 2.
Methodological and Quality Assessment of Comparative Cohort Studies (N = 50)
| Study (Name, Year) | Confounding | Study Participant Selection | Classification of Interventions | Deviation from interventions | Missing Data | Outcome Measurement | Reporting Bias |
|---|---|---|---|---|---|---|---|
| Rodriguez 2014 | Low | Low | Low | Low | Low | Moderate | Low |
| Zawadasky 2014 | Low | Low | Low | Low | Low | NI | Low |
| Bergin 2011 | Moderate | Low | Low | Low | Low | Moderate | Low |
| Hananouchi 2009 | Moderate | Low | Low | Low | Low | NI | Low |
| Sugano 2009 | Low | Moderate | Low | Low | Low | NI | Low |
| Nakata 2009 | Moderate | Low | Low | Low | Low | Moderate | Low |
| Spaans 2012 | Moderate | Low | Low | Low | Low | NI | Low |
| Fransen 2016 | Moderate | Low | Low | Low | Low | Low | Low |
| Tsukada 2015 | Moderate | Low | Moderate | Moderate | Low | NI | Low |
| Hamilton 2015 | Low | Low | Low | Moderate | Low | NI | Low |
| Tripuraneni 2016 | Low | Serious | Moderate | Low | Low | NI | Low |
| Balasubramaniam 2016 | Low | Low | Low | Low | Low | NI | Low |
| Leutch 2015 | Low | Low | Low | Low | Low | NI | Low |
| L'Hommedieu 2016 | Low | Low | Moderate | Low | Low | NI | Low |
| Malek 2016 | Low | Low | Low | Low | Serious | Moderate | Low |
| Poehling-Monaghan 2015 | Low | Low | Low | Low | Low | Moderate | Low |
| Panichkul 2016 | Moderate | Low | Low | Moderate | Low | Low | Low |
| Sheth 2015 | Low | Low | Low | Low | Low | Low | Low |
| Chomiak 2015 | Moderate | Low | Low | Low | Low | NI | Low |
| Purcell 2018 | Low | Low | Low | Low | Low | Low | Moderate |
| Zjilstra 2017 | Low | Low | Low | Low | Low | Low | Low |
| Petis 2016 | Low | Low | Low | Moderate | Low | NI | Low |
| Pogliacomi & De Filippo 2012 | Low | Low | Low | Low | Unclear | NI | Low |
| Pogliacomi & Paraskevopoulos 2012 | Moderate | Low | Low | Low | Low | NI | Low |
| Schliecher 2011 | Low | Low | Low | Low | NI | Moderate | Low |
| Alecci 2011 | Moderate | Low | Low | Moderate | Low | NI | Low |
| Ilchmann 2013 | Serious | Serious | Moderate | Low | Low | NI | Low |
| Berend 2009 | Low | Serious | Low | Low | Low | Low | Low |
| Reichert 2015 | Moderate | Low | Low | Low | Moderate | NI | Low |
| Chen 2016 | Low | Low | Low | Low | Low | Low | Low |
| Ilchmann 2016 | Moderate | Serious | Low | Moderate | Low | Moderate | Low |
| Bernasek 2010 | Moderate | Low | Low | Low | Low | Low | Low |
| Downing 2001 | Moderate | Serious | Low | Low | Serious | Moderate | Low |
| Vicente 2008 | Moderate | Serious | Moderate | Low | Serious | Moderate | Serious |
| Jameson 2014 | Low | Low | Low | Low | Low | Moderate | Low |
| Arthursson 2007 | Low | Low | Low | Low | Low | Low | Low |
| Sendtner 2011 | Low | Low | Low | Low | Unclear | Moderate | Low |
| Amlie 2014 | Moderate | Low | Low | Low | Low | Moderate | Low |
| Smith 2012 | Moderate | Low | Low | Low | Moderate | Moderate | Low |
| Carlson 1987 | Low | Low | Low | Low | NI | NI | Low |
| Ritter 2001 | NI | Low | Low | Low | Low | NI | Low |
| Laffosse 2007 | Moderate | Low | Low | Low | Unclear | Moderate | Low |
| Edmunds 2011 | Serious | Moderate | Low | NI | Serious | NI | Serious |
| Abdel 2016 | Moderate | Serious | Low | Moderate | Low | Low | Low |
| Takao 2016 | Moderate | Low | Low | Low | Low | Moderate | Low |
| Jelsma 2016 | Low | Low | Moderate | Low | Moderate | NI | Low |
| Wayne 2009 | Low | Serious | Low | Low | Low | NI | Serious |
| Ponzio 2018 | Low | Moderate | Low | Low | Low | Low | Low |
| Aggrawal 2019 | Low | Low | Low | Low | Low | NI | Low |
NI: Not indicated.
APPENDIX D. GRADE ASSESSMENT FOR INCLUDED STUDIES
Table 1.
Summary of Findings and Evidence Profile Table for Anterior versus Posterior Approach Studies.
| Complication | Number of Studies | GRADE Assessment |
Overall Quality (GRADE) | ||||
|---|---|---|---|---|---|---|---|
| Limitations | Inconsistency | Indirectness | Imprecision | Publication Bias | |||
| Dislocation*† | 3 RCTs | Serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊖⊖ |
| 22 Cohorts | Serious limitations | No serious inconsistency | No serious indirectness | No serious imprecision | Strongly suspected | ⊕⊖⊖⊖ | |
| Intraoperative Femoral Fracture | 3 RCTs | No serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊖⊖ |
| 6 Cohorts | No serious limitations | Serious inconsistency | No serious indirectness | Very serious imprecision | Strongly suspected | ⊕⊖⊖⊖ | |
| Intraoperative Acetabular Fracture | 2 Cohorts | No serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊖⊖⊖ |
| Intraoperative “Other” Fracture | 3 Cohorts | Serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊖⊖⊖ |
| Postoperative Femoral Fracture* | 1 RCT | Serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊖⊖ |
| 1 Cohort | No serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊖⊖⊖ | |
| Postoperative “Other” Fracture* | 3 Cohorts | No serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊖⊖⊖ |
| Wound Complication† | 4 RCT | Serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊖⊖ |
| 3 Cohorts | Serious limitations | Very serious inconsistency | No serious indirectness | Serious imprecision | Strongly suspected | ⊕⊖⊖⊖ | |
| Infection* | 3 Cohorts | No serious limitations | Serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊖⊖⊖ |
| DVT† | 1 RCT | Serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊖⊖ |
| 3 Cohorts | No serious limitations | No serious inconsistency | No serious indirectness | No serious imprecision | Undetected | ⊕⊖⊖⊖ | |
| Loosening† | 5 Cohorts | Serious limitations | No serious inconsistency | No serious indirectness | No serious imprecision | Strongly suspected | ⊕⊖⊖⊖ |
| *Early (within 90 days) †Unknown Time | |||||||
Table 2.
Summary of meta-analyses on complications in Lateral versus Anterior Approach Studies.
| Complication | Number of Studies | GRADE Assessment |
Overall Quality (GRADE) | ||||
|---|---|---|---|---|---|---|---|
| Limitations | Inconsistency | Indirectness | Imprecision | Publication Bias | |||
| Dislocation*† | 12 Cohorts | Serious limitations | Serious inconsistency | No serious indirectness | No serious imprecision | Undetected | ⊕⊖⊖⊖ |
| 3 RCTs | Serious limitations | No serious inconsistency | No serious indirectness | Serious imprecision | Undetected | ⊕⊕⊕⊖ | |
| Intraoperative Femoral Fracture | 2 RCTs | No serious limitations | No serious inconsistency | No serious indirectness | Serious imprecision | Undetected | ⊕⊕⊕⊖ |
| 3 Cohorts | Serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊖⊖⊖ | |
| Intraoperative Acetabular Fracture | 1 Cohort | Serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊖⊖⊖ |
| Intraoperative “Other” Fracture | 1 RCT | No serious limitations | No serious inconsistency | No serious indirectness | Serious imprecision | Undetected | ⊕⊕⊖⊖ |
| 5 Cohorts | No serious limitations | Serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊖⊖⊖ | |
| Postoperative Femoral Fracture* | 2 Cohort | Serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊖⊖⊖ |
| Postoperative Acetabular Fracture* | 1 Cohort | Serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊖⊖⊖ |
| Postoperative “Other” Fracture* | 1 Cohort | Serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊖⊖⊖ |
| Infection* | 3 RCT | No serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊕⊖ |
| 2 Cohorts | No serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊖⊖⊖ | |
| DVT† | 2 RCT | No serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊕⊖ |
| 4 Cohorts | Serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Strongly suspected | ⊕⊖⊖⊖ | |
| Loosening† | 4 Cohorts | No serious limitations | Serious inconsistency | No serious indirectness | Very serious imprecision | Strongly suspected | ⊕⊖⊖⊖ |
| 2 RCT | No serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊖⊖ | |
*Early (within 90 days), †Unknown Time.
Table 3.
Summary of Findings and Evidence Profile for Complications in Lateral versus Anterolateral Approach Studies.
| Complication | Number of Studies | GRADE Assessment |
Overall GRADE | ||||
|---|---|---|---|---|---|---|---|
| Limitations | Inconsistency | Indirectness | Imprecision | Publication Bias | |||
| Dislocation*† | 3 RCTs | Serious limitation | No serious inconsistency | No serious indirectness | Very serious imprecision | Strongly suspected | ⊕⊕⊖⊖ |
| 4 Cohort | Serious limitations | No serious inconsistency | No serious indirectness | Serious imprecision | Undetected | ⊕⊖⊖⊖ | |
| Intraoperative Femoral Fracture | 2 RCTs | No serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊕⊖ |
| 2 Cohort | No serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊖⊖ | |
| Intraoperative “Other” Fracture | 1 Cohort | No serious limitations | No serious inconsistency | No serious indirectness | Serious imprecision | Undetected | ⊕⊖⊖⊖ |
| Wound Complication† | 2 RCTs | No serious limitations | Serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊖⊖ |
| Infection* | 2 RCTs | No serious limitations | Serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊖⊖ |
| DVT† | 1 RCT | Serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊖⊖ |
| Loosening | 2 Cohorts | No serious limitations | No serious inconsistency | No serious indirectness | No serious imprecision | Undetected | ⊕⊖⊖⊖ |
*early, †unknown time.
Table 4.
Summary of Findings and Evidence Profile for Complications in Lateral versus Posterior Approach Studies.
| Complication | Number of Studies | GRADE Assessment |
Overall GRADE | ||||
|---|---|---|---|---|---|---|---|
| Limitations | Inconsistency | Indirectness | Imprecision | Publication Bias | |||
| Dislocation*† | 2 RCTs | No serious limitations | Serious inconsistency | No serious indirectness | No serious imprecision | Undetected | ⊕⊕⊖⊖ |
| 10 Cohorts | Serious limitations | Serious inconsistency | No serious indirectness | Very serious imprecision | Strongly suspected | ⊕⊖⊖⊖ | |
| Intraoperative Femoral Fracture | 2 RCTs | No serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊕⊖ |
| 2 Cohorts | Serious limitations | Serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊖⊖⊖ | |
| Postoperative “Other” Fracture* | 1 Cohort | Serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊖⊖ |
| Infection* | 1 RCT | No serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊕⊖ |
| DVT† | 1 RCT | No serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊕⊖ |
| 2 Cohorts | No serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊖⊖⊖ | |
| Loosening† | 4 Cohorts | Serious limitations | No serious inconsistency | No serious indirectness | No serious imprecision | Undetected | ⊕⊖⊖⊖ |
| *Early (within 90 days) †Unknown Time | |||||||
Table 5.
Summary of Findings and Evidence Profile for Complications in Anterolateral versus Posterior Approach Studies.
| Complication | Number of Studies | GRADE Assessment |
Overall GRADE | ||||
|---|---|---|---|---|---|---|---|
| Limitations | Inconsistency | Indirectness | Imprecision | Publication Bias | |||
| Dislocation*† | 10 Cohorts | Serious limitations | Serious inconsistency | No serious indirectness | No serious imprecision | Strongly suspected | ⊕⊖⊖⊖ |
| 1 RCT | No serious limitations | Serious inconsistency | No serious indirectness | No serious imprecision | Undetected | ⊕⊕⊕⊖ | |
| Intraoperative Femoral Fracture | 1 RCT | No serious limitations | Serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊖⊖ |
| 1 Cohort | Serious limitations | Serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊖⊖⊖ | |
| Wound Complication† | 1 Cohort | No serious limitations | Serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊖⊖⊖ |
| Infection* | 2 RCTs | No serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Strongly suspected | ⊕⊕⊕⊖ |
| 1 Cohort | Serious limitation | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊖⊖⊖ | |
| DVT† | 1 Cohort | No serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊖⊖⊖ |
| Loosening† | 1 RCT | No serious limitations | No serious inconsistency | No serious indirectness | Very serious imprecision | Undetected | ⊕⊕⊖⊖ |
| 2 cohort | No serious limitations | No serious inconsistency | No serious indirectness | No serious imprecision | Undetected | ⊕⊖⊖⊖ | |
*Early (within 90 days), †Unknown Time.
References
- 1.Healy W.L., Iorio R., Clair A.J., Pellegrini V.D., Della Valle C.J., Berend K.R. Complications of total hip arthroplasty: standardized list, definitions, and stratification developed by the hip society. Clin Orthop Relat Res. 2016 Feb;474(2):357–364. doi: 10.1007/s11999-015-4341-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Saleh K.J., Kassim R., Yoon P., Vorlicky L.N. Complications of total hip arthroplasty. Am J Orthoped. 2002 Aug;31(8):485–488. [PubMed] [Google Scholar]
- 3.Palan J., Manktelow A. Surgical approaches for primary total hip replacement. Orthop Traumatol. 2018 Feb;32(1):1–12. [Google Scholar]
- 4.Chechik O., Khashan M., Lador R., Salai M., Amar E. Surgical approach and prosthesis fixation in hip arthroplasty world wide. Arch Orthop Trauma Surg. 2013 Nov;133(11):1595–1600. doi: 10.1007/s00402-013-1828-0. [DOI] [PubMed] [Google Scholar]
- 5.Onyemaechi N., Anyanwu E., Obikili E., Ekezie J. Anatomical basis for surgical approaches to the hip. Ann Med Health Sci Res. 2014 Jul;4(4):487–494. doi: 10.4103/2141-9248.139278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Masonis J.L., Bourne R.B. Surgical approach, abductor function, and total hip arthroplasty dislocation. Clin Orthop Relat Res. 2002 Dec;(405):46–53. doi: 10.1097/00003086-200212000-00006. [DOI] [PubMed] [Google Scholar]
- 7.Mulliken B.D., Rorabeck C.H., Bourne R.B., Nayak N. The surgical approach to total hip arthroplasty: complications and utility of a modified direct lateral approach. Iowa Orthop J. 1995;15:48–61. [PMC free article] [PubMed] [Google Scholar]
- 8.Christensen C.P., Karthikeyan T., Jacobs C.A. Greater prevalence of wound complications requiring reoperation with direct anterior approach total hip arthroplasty. J Arthroplasty. 2014 Sep;29(9):1839–1841. doi: 10.1016/j.arth.2014.04.036. [DOI] [PubMed] [Google Scholar]
- 9.Tissot C., Vautrin M., Luyet A., Borens O. Are there more wound complications or infections with direct anterior approach total hip arthroplasty? HIP Int. 2018 Nov;28(6):591–598. doi: 10.1177/1120700018759617. [DOI] [PubMed] [Google Scholar]
- 10.Petis S., Howard J.L., Lanting B.L., Vasarhelyi E.M. Surgical approach in primary total hip arthroplasty: anatomy, technique and clinical outcomes. Can J Surg. 2015 Apr;58(2):128–139. doi: 10.1503/cjs.007214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Moher D., Liberati A., Tetzlaff J., Atman D., The PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Int J Surg. 2010;8(5):336–341. doi: 10.1016/j.ijsu.2010.02.007. [DOI] [PubMed] [Google Scholar]
- 12.Higgins J.P.T., Green S. Wiley; Chichester: 2008. Cochrane Handbook of Systematic Reviews of Interventions. [Google Scholar]
- 13.McHugh M.L. Interrater reliability: the kappa statistic. Biochem Med. 2012;22(3):276–282. [PMC free article] [PubMed] [Google Scholar]
- 14.Higgins J.P.T., Altman D.G., Gotzsche P.C. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011 Oct 18;343(oct18 2) doi: 10.1136/bmj.d5928. d5928–d5928. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Guyatt G., Oxman A.D., Akl E.A. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011 Apr;64(4):383–394. doi: 10.1016/j.jclinepi.2010.04.026. [DOI] [PubMed] [Google Scholar]
- 16.Higgins J.P.T., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002 Jun 15;21(11):1539–1558. doi: 10.1002/sim.1186. [DOI] [PubMed] [Google Scholar]
- 17.Zijlstra W.P., De Hartog B., Van Steenbergen L.N., Scheurs B.W., Nelissen R.G.H.H. Effect of femoral head size and surgical approach on risk of revision for dislocation after total hip arthroplasty: an analysis of 166,231 procedures in the Dutch Arthroplasty Register (LROI) Acta Orthop. 2017 Jul 4;88(4):395–401. doi: 10.1080/17453674.2017.1317515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Panichkul P., Parks N.L., Ho H., Hopper R.H., Hamilton W.G. New approach and stem increased femoral revision rate in total hip arthroplasty. Orthopedics. 2016 Jan 1;39(1):e86–92. doi: 10.3928/01477447-20151222-06. [DOI] [PubMed] [Google Scholar]
- 19.Siguier T., Siguier M., Brumpt B. Mini-incision anterior approach does not increase dislocation rate: a study of 1037 total hip replacements. Clin Orthop Relat Res. 2004 Sep;(426):164–173. doi: 10.1097/01.blo.0000136651.21191.9f. [DOI] [PubMed] [Google Scholar]
- 20.Pellicci P.M., Potter H.G., Foo L.F., Boettner F. MRI shows biologic restoration of posterior soft tissue repairs after THA. Clin Orthop Relat Res. 2009 Apr;467(4):940–945. doi: 10.1007/s11999-008-0503-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Petis S., Howard J., Lanting B., Vasarhelyi E. Surgical approach in primary total hip arthroplasty: anatomy, technique and clinical outcomes. Can J Surg. 2015 Apr 1;58(2):128–139. doi: 10.1503/cjs.007214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Kwon M.S., Kuskowski M., Mulhall K.J., Macaulay W., Brown T.E., Saleh K.J. Does surgical approach affect total hip arthroplasty dislocation rates? Clin Orthop Relat Res. 2006 Jun;447:34–38. doi: 10.1097/01.blo.0000218746.84494.df. [DOI] [PubMed] [Google Scholar]
- 23.Hailer N.P., Garellick G., Kärrholm J. Uncemented and cemented primary total hip arthroplasty in the Swedish Hip Arthroplasty Register: Evaluation of 170,413 operations. Acta Orthop. 2010 Feb;81(1):34–41. doi: 10.3109/17453671003685400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Zhang C., Yan C.H., Zhang W. Cemented or cementless fixation for primary hip arthroplasty—evidence from the International Joint Replacement Registries. Ann Joint. 2017 Oct 17;2 57–57. [Google Scholar]
- 25.Arthursson A.J., Furnes O., Espehaug B., Havelin L.I., Söreide J.A. Prosthesis survival after total hip arthroplasty—does surgical approach matter? Analysis of 19,304 Charnley and 6,002 Exeter primary total hip arthroplasties reported to the Norwegian Arthroplasty Register. Acta Orthop. 2007 Jan;78(6):719–729. doi: 10.1080/17453670710014482. [DOI] [PubMed] [Google Scholar]
- 26.Vicente J.R.N., Miyahara H.S., Luzo C.M., Gurgel H.M., Croci A.T. Total hip arthroplasty using a posterior minimally invasive approach – results after six years. Revista Brasileira de Ortopedia (English Edition) 2015 Jan;50(1):77–82. doi: 10.1016/j.rboe.2014.12.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Laffosse J.M., Chiron P., Molinier F., Bensafi H., Puget J. Prospective and comparative study of the anterolateral mini-invasive approach versus minimally invasive posterior approach for primary total hip replacement. Early results. Int Orthop. 2007 Oct 10;31(5):597–603. doi: 10.1007/s00264-006-0247-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Laffosse J.-M., Chiron P., Accadbled F., Molinier F., Tricoire J.-L., Puget J. Learning curve for a modified Watson-Jones minimally invasive approach in primary total hip replacement: analysis of complications and early results versus the standard-incision posterior approach. Acta Orthop Belg. 2006 Dec;72(6):693–701. [PubMed] [Google Scholar]
- 29.Jewett B.A., Collis D.K. High complication rate with anterior total hip arthroplasties on a fracture table. Clin Orthop Relat Res. 2011 Feb;469(2):503–507. doi: 10.1007/s11999-010-1568-1. [DOI] [PMC free article] [PubMed] [Google Scholar]






